Literature DB >> 22134236

Three-percent saline administration during pediatric critical care transport.

Johnny L Luu1, Cherry L Wendtland, Matthew F Gross, Farrukh Mirza, Alexander Zouros, Grenith J Zimmerman, Besh Barcega, Shamel A Abd-Allah.   

Abstract

OBJECTIVES: The purpose of this study was to describe the administration of 3% saline (3%S) during pediatric critical care transport.
METHODS: A retrospective study was performed on pediatric patients who underwent critical transport to Loma Linda University Children's Hospital from January 1, 2003, to June 30, 2007, and were given 3%S. Patients' demographics, admission diagnosis, route and amount of 3%S administration, serum electrolytes, vital signs, radiographic data, and Glasgow Coma Scale scores were collected and analyzed.
RESULTS: A total of 101 children who received 3%S infusions during pediatric critical care transport were identified. Mean patient age was 5.9 years, and mean patient weight was 27.6 kg. The main indications for infusing 3%S were suspected cerebral edema (41%), intracranial bleed with edema (51%), and symptomatic hyponatremia (6%). The amount of 3%S bolus ranged from 1.2 to 24 mL/kg, with a mean of 5.4 mL/kg. Serum electrolytes before and after 3%S infusion demonstrated significant increases in sodium, chloride, and bicarbonate levels (P < 0.05). A significant reduction was also seen in serum urea nitrogen levels and anion gap. Radiographic imaging performed before 3%S infusion demonstrated findings consistent with concerns of increased intracranial pressure such as intracranial bleed and cerebral edema. The route of initial 3%S infusions was mainly through peripheral intravenous lines (96%). No complications related to the 3%S delivery such as local reactions, renal abnormalities, or central pontine myelinolysis were observed.
CONCLUSIONS: It seems 3%S may be administered safely during pediatric critical transport and administration routes can include peripheral lines. With the importance of initiating therapy early to improve patient outcomes, the use of 3%S may benefit transported children with brain injury and suspected intracranial hypertension.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22134236     DOI: 10.1097/PEC.0b013e31823aff59

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  6 in total

1.  Saving Brain and Vein: Administering Hypertonic Saline Through a Peripheral IV Catheter.

Authors:  Jeremy R Herrmann; Alicia K Au
Journal:  Pediatr Crit Care Med       Date:  2022-04-07       Impact factor: 3.971

Review 2.  New trends in hyperosmolar therapy?

Authors:  Michael N Diringer
Journal:  Curr Opin Crit Care       Date:  2013-04       Impact factor: 3.687

Review 3.  Effect of hypertonic saline in the management of elevated intracranial pressure in children with cerebral edema: A systematic review and meta-analysis.

Authors:  Farzana Afroze; Monira Sarmin; C A Kawser; Sharika Nuzhat; Lubaba Shahrin; Haimanti Saha; Nusrat Jahan Shaly; Irin Parvin; Mohsena Bint-E Sharif; M Al Mamun; Tahmeed Ahmed; Mohammod Jobayer Chisti
Journal:  SAGE Open Med       Date:  2021-03-29

4.  Lidocaine coinfusion alleviates vascular pain induced by hypertonic saline infusion: a randomized, placebo-controlled trial.

Authors:  Zhiping Song; Shibiao Chen; Yang Zhang; Xiaoyun Shi; Na Zhao; Zhengyu Liao
Journal:  BMC Anesthesiol       Date:  2021-04-10       Impact factor: 2.217

5.  An exploratory assessment of the management of pediatric traumatic brain injury in three centers in Africa.

Authors:  Madiha Raees; Shubhada Hooli; Amélie O von Saint André-von Arnim; Tsegazeab Laeke; Easmon Otupiri; Anthony Fabio; Kristina E Rudd; Rashmi Kumar; Patrick T Wilson; Abenezer Tirsit Aklilu; Lisine Tuyisenge; Chunyan Wang; Robert C Tasker; Derek C Angus; Patrick M Kochanek; Ericka L Fink; Tigist Bacha
Journal:  Front Pediatr       Date:  2022-08-17       Impact factor: 3.569

6.  A Survey of Hospital Pharmacy Guidelines for the Administration of 3% Sodium Chloride in Children.

Authors:  Siddharth A Shah; Juan C Ayus; Michael L Moritz
Journal:  Children (Basel)       Date:  2022-01-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.